• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

EUSA Pharma

edit

EUSA Pharma, Inc. operates as a specialty pharmaceutical company. It engages in the in-licensing, developing, and marketing of late-stage oncology, pain control, and critical care products. The company’s products include Caphosol for the treatment of oral mucositis; ProstaScint for imaging the extent and spread of prostate cancer; Quadramet for the treatment of pain in patients whose cancer has spread to the bones; Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia; and Collatamp G for the treatment and prevention of post-surgical infection. It also provides Rapydan, a medicated plaster; Fomepizole, a specific pharmacological antidote indicated for the treatment of ethylene glycol poisoning; and Xenazine for the treatment of Huntington’s chorea. EUSA Pharma, Inc. was founded in 2006 and is based in Oxford, the United Kingdom with corporate offices in the United States and the United Kingdom.

Milestones

edit

• 
  EUSA Pharma added Stephen A. Stamp as Non-executive Director.
  Posted 9/6/10 at 8:12pm
• 
  EUSA Pharma added David Cook as CFO.
  Posted 9/6/10 at 8:12pm
• 
  EUSA Pharma added Bryan Morton as President & CEO.
  Posted 9/6/10 at 8:12pm
• 
  EUSA Pharma received $12.5M in Venture Round funding. (12/13/05)
  Posted 7/3/10 at 12:26am
• 
  EUSA Pharma received $14M in Venture Round funding. (7/19/05)
  Posted 7/2/10 at 5:32am
• 
  EUSA Pharma received $18.6M in Venture Round funding. (11/7/06)
  Posted 4/21/10 at 9:48pm
• 
  EUSA Pharma received $9.1M in Venture Round funding. (6/28/07)
  Posted 3/15/10 at 3:10am
• 
  EUSA Pharma acquired EUSA Pharma (USA) for $22.6M. (3/10/08)
  Posted 9/7/09 at 6:01pm
• 
  EUSA Pharma was acquired by Jazz Pharmaceuticals for $650M. (4/26/12)
  Posted 4/26/12 at 7:54pm via dowjones.com

Videos

Screenshots

edit

Above: EUSA Pharma
Uploaded: 3/15/10

Sources

1. Jazz Pharma Agrees To Buy EUSA Pharma For $650M (pevc.dowjones.com) [edit]
2. Citation Needed [add]
3. Cap Funding Report [edit]
4. Cap Funding Report [edit]
5. Cap Funding Report [edit]
6. Cap Funding Report [edit]